AdCure Bio is a pre-clinical stage cancer viro-immuno-therapy company, developing potent and safe immuno-stimulatory oncolytic viruses for therapy of solid tumors. AdCure Bio is committed to bring patients new therapies for late-stage and disseminated metastatic cancers, refractory to immunotherapy, chemotherapy and other existing treatment modalities.
View Top Employees from AdCure Bio. LLCWebsite | https://adcurebio.com |
Revenue | $4 million |
Employees | 5 (3 on RocketReach) |
Founded | 2016 |
Address | 6000 Lake Forrest Dr NW Suite 400, Atlanta, Georgia 30303, US |
Phone | (206) 334-6511 |
Technologies |
JavaScript,
HTML,
Twitter
+6 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Business Services |
Competitors | American Gene Technologies® International Inc., Amphivena Therapeutics Inc., Batu Biologics, Inc., ENB Therapeutics, PxRadia, Inc. |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies |
Looking for a particular AdCure Bio. LLC employee's phone or email?
The AdCure Bio. LLC annual revenue was $4 million in 2024.
Dmitry Shayakhmetov is the Co-Founder and Chief Scientific Officer of AdCure Bio. LLC.
3 people are employed at AdCure Bio. LLC.
AdCure Bio. LLC is based in Atlanta, Georgia.
The NAICS codes for AdCure Bio. LLC are [541714, 541, 54, 5417, 54171].
The SIC codes for AdCure Bio. LLC are [873, 87].